Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
|Articles|October 30, 2017
- October 2017 Diabetes
- Volume 83
- Issue 10
Can You Read These Rxs? (October 2017)
Can you figure out what these prescriptions say?
Advertisement
Send in your eye-straining, baffling prescriptions—now via e-mail and fax as well as regular mail! Submissions must include a clean photocopy or scanned image of the Rx; your institution’s name and location; your name and title; the correct name of the drug(s), strength, and dosing requirements; and your phone number. You can e-mail scanned Rxs to rmarotta@pharmacytimes.com; fax them to 609-257-0701; or mail them to Can You Read These Rxs?, Pharmacy Times, 2 Clarke Drive, Suite 100, Cranbury, NJ 08512.
Articles in this issue
almost 9 years ago
Case Studies (October 2017)almost 9 years ago
Pet Peeves (October 2017)almost 9 years ago
Rx Product News (October 2017)almost 9 years ago
Ingrezzaalmost 9 years ago
OTC Product News (October 2017)almost 9 years ago
Self-Care for Diabetesalmost 9 years ago
Are Fad Diets Just a Fad?almost 9 years ago
Does an Employee Have Access to Her PDMP Database Records?almost 9 years ago
Who Is to Blame for the Opioid Crisis?almost 9 years ago
Vaccine Abbreviations and Acronyms Contribute to ErrorsAdvertisement
Related to this article
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
Pneumonic Plague: What Pharmacists Need to Know About Treatment
3
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
4
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
5